Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
enterovirus type 71 vaccine, inactivated (human diploid cell)
- Development stage
- Unknown
- Lead developer
- Institute of Medical Biology Chinese Academy of Medical Sciences
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
An inactivated viral vaccine developed by the Institute of Medical Biology, Chinese Academy of Medical Sciences (IMBCAMS) for the prevention of hand, foot, and mouth disease (HFMD) caused by Enterovirus 71 (EV71) infection. The vaccine is produced using the KMB17 human diploid cell line, which is intended to provide a high safety profile and consistent immunogenicity. It works by inducing specific neutralizing antibodies against the EV71 virus. It was the first human diploid cell-based EV71 vaccine to be approved and marketed in China, specifically targeting children aged 6 months to 5 years.
- Brand names
- Yi Wei Fu
- Other names
- EV71 vaccine (human diploid cell)Inactivated Enterovirus Type 71 Vaccine (Human Diploid Cell)Enterovirus Type 71 Vaccine, Inactivated (Human Diploid Cell)
02
Targets
Enterovirus A71 capsid proteinEnterovirus 71 capsid protein VP2
Beyond the preview
Go deeper on enterovirus type 71 vaccine, inactivated (human diploid cell).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on enterovirus type 71 vaccine, inactivated (human diploid cell).